Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Advanced Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, St Louis, Missouri, United States
Research Site, East Providence, Rhode Island, United States
Research Site, Nashville, Tennessee, United States
Research Site, Cambridge, United Kingdom
Research Site, London, United Kingdom
Research Site, Manchester, United Kingdom